Literature DB >> 2199529

Septicemia caused by vancomycin-resistant Pediococcus acidilactici.

C L Golledge1, N Stingemore, M Aravena, D Joske.   

Abstract

A case of septicemia caused by vancomycin-resistant Pediococcus acidilactici is discussed. This appears to be the first reported case of septicemia caused by this organism. The characteristics and antimicrobial susceptibilities of this organism are described.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2199529      PMCID： PMC268018          DOI： 10.1128/jcm.28.7.1678-1679.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  6 in total

1.  Vancomycin-resistant enterococci.

Authors:  A H Uttley; C H Collins; J Naidoo; R C George
Journal:  Lancet       Date:  1988 Jan 2-9       Impact factor: 79.321

2.  Vancomycin resistant lactobacilli.

Authors:  C Golledge
Journal:  J Hosp Infect       Date:  1988-04       Impact factor: 3.926

3.  Vancomycin-resistant leuconostocs, lactobacilli and now pediococci.

Authors:  G Colman; A Efstratiou
Journal:  J Hosp Infect       Date:  1987-07       Impact factor: 3.926

4.  Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium.

Authors:  R Leclercq; E Derlot; J Duval; P Courvalin
Journal:  N Engl J Med       Date:  1988-07-21       Impact factor: 91.245

5.  Identification of gram-positive coccal and coccobacillary vancomycin-resistant bacteria.

Authors:  R Facklam; D Hollis; M D Collins
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

6.  Vancomycin-resistant gram-positive bacteria isolated from human sources.

Authors:  K L Ruoff; D R Kuritzkes; J S Wolfson; M J Ferraro
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948
  6 in total
  9 in total

1.  Characterization and antibiotic susceptibility of Pediococcus acidilactici strains isolated from neutropenic patients.

Authors:  J Maugein; P Crouzit; P Cony Makhoul; J Fourche
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

2.  Pediococcus acidilactici pneumonitis and bacteremia in a pregnant woman.

Authors:  P S Sarma; S Mohanty
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

Review 3.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

4.  In vitro activities of ketolide HMR3647, macrolides, and other antibiotics against Lactobacillus, Leuconostoc, and Pediococcus isolates.

Authors:  M Zarazaga; Y Sáenz; A Portillo; C Tenorio; F Ruiz-Larrea; R Del Campo; F Baquero; C Torres
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

5.  Quinupristin-dalfopristin resistance among gram-positive bacteria in Taiwan.

Authors:  K T Luh; P R Hsueh; L J Teng; H J Pan; Y C Chen; J J Lu; J J Wu; S W Ho
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

Review 6.  Identification, classification, and clinical relevance of catalase-negative, gram-positive cocci, excluding the streptococci and enterococci.

Authors:  R Facklam; J A Elliott
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

7.  Antimicrobial susceptibility of Pediococcus spp. and genetic basis of macrolide resistance in Pediococcus acidilactici HM3020.

Authors:  J Tankovic; R Leclercq; J Duval
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

8.  Septicemia and hepatic abscess caused by Pediococcus acidilactici.

Authors:  J M Sire; P Y Donnio; R Mesnard; P Pouëdras; J L Avril
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

9.  Resolution of Pediococcus acidilactici bacteremia without antibiotic therapy in a 16-year-old adolescent with leukemia receiving maintenance chemotherapy.

Authors:  Jun Tachikawa; Yuta Aizawa; Ryohei Izumita; Chansu Shin; Chihaya Imai; Akihiko Saitoh
Journal:  IDCases       Date:  2022-01-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.